Red De Terapia Celular
🇪🇸Spain
- Country
- 🇪🇸Spain
- Ownership
- Private
- Established
- 2006-01-01
- Employees
- 251
- Market Cap
- -
- Website
- https://www.red-tercel.com
Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stem Cells
Phase 2
Completed
- Conditions
- COVID-19 Pneumonia
- Interventions
- Other: PlaceboBiological: Mesenchymal Stem Cells (MSCs)
- First Posted Date
- 2020-04-24
- Last Posted Date
- 2024-02-02
- Lead Sponsor
- Red de Terapia Celular
- Target Recruit Count
- 24
- Registration Number
- NCT04361942
- Locations
- 🇪🇸
Hospital Universitario Rio Hortega, Valladolid, Spain
Treatment of Lupus Nephritis With Allogeneic Mesenchymal Stem Cells
Phase 2
Recruiting
- Conditions
- Lupus NephritisLupus Erythematosus
- Interventions
- Drug: Mesenchymal stem cells (MSC)Drug: Placebo
- First Posted Date
- 2018-09-17
- Last Posted Date
- 2024-04-10
- Lead Sponsor
- Red de Terapia Celular
- Target Recruit Count
- 20
- Registration Number
- NCT03673748
- Locations
- 🇪🇸
University Hospital Río Hortega, Valladolid, Spain
Clinical Trial of Intravenous Infusion of Fucosylated Bone Marrow Mesenchyme Cells in Patients With Osteoporosis
Phase 1
Completed
- Conditions
- OsteoporosisSpinal Fractures
- Interventions
- Biological: Fucosylated MSC for Osteoporosis
- First Posted Date
- 2015-10-02
- Last Posted Date
- 2020-10-08
- Lead Sponsor
- Red de Terapia Celular
- Target Recruit Count
- 10
- Registration Number
- NCT02566655
- Locations
- 🇪🇸
Hospital Clínico Virgen de la Arrixaca, El Palmar, Murcia, Spain
Clinical Trial of Use of Autologous Bone Marrow Stem Cells Seeded on Porous Tricalcium Phosphate Matrix and Demineralized Bone Matrix in Patients With Osteonecrosis
Phase 1
- Conditions
- Osteonecrosis of Jaw
- Interventions
- Biological: MSC construct for Osteonecrosis
- First Posted Date
- 2015-10-02
- Last Posted Date
- 2017-03-30
- Lead Sponsor
- Red de Terapia Celular
- Target Recruit Count
- 10
- Registration Number
- NCT02566681
- Locations
- 🇪🇸
Hospital Clínico Virgen de la Arrixaca, El Palmar, Murcia, Spain
Lumbar Degenerative Disc Disease Treatment With Bone Marrow Autologous Mesenchymal Stem Cells (MSV)
Phase 1
Withdrawn
- Conditions
- Degenerative Disc Disease
- Interventions
- Other: Autologous bone marrow mesenchymal stem cells
- First Posted Date
- 2015-05-12
- Last Posted Date
- 2015-05-12
- Lead Sponsor
- Red de Terapia Celular
- Registration Number
- NCT02440074
Intramuscular Infusion of Autologous Bone Marrow Stem Cells in Patients With Amyotrophic Lateral Sclerosis
Phase 1
- Conditions
- ALS (Amyotrophic Lateral Sclerosis)
- Interventions
- Biological: MNC (Mononuclear cells)Other: Saline
- First Posted Date
- 2014-11-07
- Last Posted Date
- 2017-03-30
- Lead Sponsor
- Red de Terapia Celular
- Target Recruit Count
- 20
- Registration Number
- NCT02286011
- Locations
- 🇪🇸
Clinical Universitary Hospital Virgen de la Arrixaca, El Palmar, Murcia, Spain
Clinical Trial of Intravitreal Injection of Autologous Bone Marrow Stem Cells in Patients With Retinitis Pigmentosa
Phase 1
Completed
- Conditions
- Retinitis Pigmentosa
- Interventions
- Other: Subconjunctival injection of salineBiological: Intravitreal injection of Autologous bone marrow Stem Cell
- First Posted Date
- 2014-10-31
- Last Posted Date
- 2017-03-30
- Lead Sponsor
- Red de Terapia Celular
- Target Recruit Count
- 8
- Registration Number
- NCT02280135
- Locations
- 🇪🇸
Clinical Universitary Hospital Virgen de la Arrixaca, El Palmar, Murcia, Spain
Clinical Trial In The Treatment Of Allogeneic Post-Transplant Cytopenias With Sequential Infusion Of Allogeneic Mesenchymal Cells Expanded In Vitro
Phase 2
Completed
- Conditions
- Cytopenia
- Interventions
- Biological: Sequential infusion of allogeneic mesenchymal stem cells expanded "in vitro"
- First Posted Date
- 2014-04-04
- Last Posted Date
- 2017-03-30
- Lead Sponsor
- Red de Terapia Celular
- Target Recruit Count
- 15
- Registration Number
- NCT02104440
- Locations
- 🇪🇸
University Clinical Hospital of Salamanca, Salamanca, Salamanca/Castilla León, Spain
Clinical Trial Phase I/II Prospective, Open Nonrandomized for Treatmen of Postoperative Air Leak After Lung Resection in High Risk Patients Through the Administration of Mesenchymal Autologous Cells
Phase 1
- Conditions
- Postoperative Air Leaks in Risk Patients
- Interventions
- Biological: Implantation of autologous mesenchymal stem cells (CSM) expanded "in vitro" and administered directly into the lung suture line
- First Posted Date
- 2014-01-27
- Last Posted Date
- 2017-03-30
- Lead Sponsor
- Red de Terapia Celular
- Target Recruit Count
- 10
- Registration Number
- NCT02045745
- Locations
- 🇪🇸
University Clinical Hospital of Salamanca, Salamanca, Salamanca/Castilla León, Spain
Treatment of Degenerative Disc Disease With Allogenic Mesenchymal Stem Cells (MSV)
Phase 1
Completed
- Conditions
- Low Back PainIntervertebral Disc DiseaseDegenerative Disc Disease
- Interventions
- Biological: Allogenic Mesenchymal Stromal Cells
- First Posted Date
- 2013-05-22
- Last Posted Date
- 2024-04-29
- Lead Sponsor
- Red de Terapia Celular
- Target Recruit Count
- 24
- Registration Number
- NCT01860417
- Locations
- 🇪🇸
Hospital Clinico Universitario, Valladolid, Spain
🇪🇸Instituto de Biologia y Genetica Molecular, Valladolid, Spain
© Copyright 2025. All Rights Reserved by MedPath